UPDATE: Important information about LabCorp's response to COVID-19 Read more >>>

News Releases

Date Title and Summary Additional Formats
Mar 02, 2020
LabCorp Is Scheduled to Present at the 2020 Barclays Global Healthcare Conference
BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the Barclays Global Healthcare Conference in Miami Beach on Tuesday, March 10 at 8:30 a.m. ET .
Feb 13, 2020
LabCorp Announces 2019 Fourth Quarter and Full Year Results and Provides 2020 Guidance
Revenue: Q4 of $3.0 billion , up 6% over 2018; Full year of $11.6 billion , up 2% over 2018 Diluted EPS: Q4 of $2.32 , up from $1.56 last year; Full year of $8.35 , down from $8.61 last year Adjusted EPS: Q4 of $2.86 , up 13% over 2018; Full year of $11.32 , up 3% over 2018 Free Cash Flow: Q4 of
Jan 21, 2020
LabCorp Earns 100 Percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality
Receives Designation as a Best Place to Work for LGBTQ Equality For Third Consecutive Year BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 21, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it received a perfect
Jan 14, 2020
LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and Pan-Cancer Assay for Use in Oncology Research and Development
BURLINGTON, N.C. & CARLSBAD, Calif. --(BUSINESS WIRE)--Jan. 14, 2020-- LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion diagnostics as well as other future oncology and precision medicine
Jan 13, 2020
LabCorp to Announce Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020
BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- LabCorp® (NYSE: LH) will release its fourth quarter and full year 2019 financial results before the market opens on Thursday, Feb. 13, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.
Jan 13, 2020
LabCorp and Covance Launch Extensive Preclinical, Clinical and Post-Approval Cell and Gene Therapy Development Solutions
Specialized Expertise, Coordinated Capabilities and Targeted Investments Designed to Accelerate Development and Reduce Risk for Sponsors BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- LabCorp® (NYSE:LH), a leading global life sciences company that is deeply integrated in guiding patient care,
Jan 06, 2020
LabCorp is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2020-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14 at 1:30 p.m. (PT) .